AmerisourceBergen Corporation with ticker code (ABC) now have 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 225 and 190 with the average target price sitting at $209.57. Now with the previous closing price of $180.40 and the analysts are correct then we can expect a percentage increase in value of 16.2%. The 50 day MA is $187.65 and the 200 day MA is $169.57. The company has a market capitalization of 36.35B. The stock price for the company is currently 180.98 USD
The potential market cap would be $42,228,301,692 based on the market consensus.
The company has a dividend yield of 1.09%. Other points of data to note are a P/E ratio of 22.02, revenue per share of 1247.29 and a 2.7% return on assets.
AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company’s U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The Company also focuses on specialty services and a global platform of pharma manufacturer services capabilities.
